Sutro Biopharma Inc logo

Sutro Biopharma Inc

NAS:STRO (USA)  
$ 1.93 +0.06 (+3.21%) 11:09 PM EST
At Loss
P/B:
1.39
Market Cap:
$ 154.20M
Enterprise V:
$ -208.37M
Volume:
484.59K
Avg Vol (2M):
1.10M
Trade In:
Volume:
484.59K
At Loss
Avg Vol (2M):
1.10M

Business Description

Description
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 15.62
Equity-to-Asset 0.25
Debt-to-Equity 0.22
Debt-to-EBITDA -0.38
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.38
Distress
Grey
Safe
Beneish M-Score -1.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.16
9-Day RSI 29.03
14-Day RSI 29.88
6-1 Month Momentum % -18.24
12-1 Month Momentum % -40.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.09
Quick Ratio 3.09
Cash Ratio 2.96
Days Sales Outstanding 44.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.1
Shareholder Yield % -50.48

Financials (Next Earnings Date:2025-03-25 Est.)

STRO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:STRO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sutro Biopharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 160.955
EPS (TTM) ($) -1.61
Beta 1.36
Volatility % 104.06
14-Day RSI 29.88
14-Day ATR ($) 0.212993
20-Day SMA ($) 2.3675
12-1 Month Momentum % -40.1
52-Week Range ($) 1.7 - 6.13
Shares Outstanding (Mil) 82.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sutro Biopharma Inc Filings

Filing Date Document Date Form
No Filing Data

Sutro Biopharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sutro Biopharma Inc Frequently Asked Questions

What is Sutro Biopharma Inc(STRO)'s stock price today?
The current price of STRO is $1.93. The 52 week high of STRO is $6.13 and 52 week low is $1.70.
When is next earnings date of Sutro Biopharma Inc(STRO)?
The next earnings date of Sutro Biopharma Inc(STRO) is 2025-03-25 Est..
Does Sutro Biopharma Inc(STRO) pay dividends? If so, how much?
Sutro Biopharma Inc(STRO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1